The Pivot Park Screening Centre is an open, innovative setting for the automation of extensive cellular and biochemical in-vitro screening experiments and High Throughput Screening (HTS) services.
PPSC builds on the long-established history of pharmaceutical research in Oss, the Netherlands. The Dutch pharmaceutical company Organon was established in Oss in 1923 and developed into a successful international business. Almost eighty-five years later, Organon was taken over by Schering Plough in 2007, and then again by MSD in 2009. Subsequent reorganisation and re-structuring of the company saw the research labs in Oss, the Netherlands, close, but the decision was made to ensure the availability of state-of-the-art research facilities in a new life sciences park: Pivot Park.
The Pivot Park facilities include MSD’s former screening centre, now the Pivot Park Screening Centre, which comprise two unique robotic systems for in-vitro screening. Because the new screening centre was able to retain a significant number of the original screening staff, it offers a wealth of experience in assay development, screening and automation in a new, open setting.